This cream is effective for the noninvasive treatment of actinic keratosis and basal cell carcinoma on the face and scalp. Also ideal for patients who seek reduction of skin crepiness, dullness and discoloration due to photodamage in areas with prolonged exposure to the sun, such as the décolletage, face and balding scalp.
“Zyclara represents a scientific breakthrough in treatment of actinic keratosis and could transform how this disease is managed and treated” – Julie Russak, MD, FAAD
FREQUENTLY ASKED QUESTIONS
HOW DOES ZYCLARA WORK?
Zyclara contains the active ingredient of the imiquimod molecule, which is induces the body’s cell immune response to eliminate precancerous lesions (actinic keratosis), cancerous lesions (basal cell carcinoma) as well areas of photodamaged skin, due to its antitumoral and antiviral activities in the body.
WHAT IS THE RECOVERY?
The patient will continue treatment of applying the 2.5% Imiquimod cream on the area of treatment once daily for 2 weeks followed by 2 weeks of no treatment for recovery for a total timeframe prescribed by the doctor. Early discontinuation of treatment may occur due to discomfort, and reconvened upon discretion of the doctor.
WHAT CAN YOU EXPECT?
The induction of the immune response may cause flu-like symptoms, as well as local skin reactions such as mild skin irritation, itching, dryness, flaking, scabbing, crusting, redness, or hardening of the skin where the medicine was applied.
WHAT ARE THE RESULTS?
The treatment brightens dull and uneven skin tone, enhances the texture of crepey, photodamaged skin and removes lesions of actinic keratosis and basal cell carcinoma for the emergence of younger, healthier looking skin.